SEC Form 4 · accession 0001136261-17-000008
PERNIX THERAPEUTICS HOLDINGS, INC. · PTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Pina
Officer — S VP, Gen Counsel and Comp Off
Period of report
Jan 4, 2017
Accepted (ET)
Jan 17, 2017 · 4:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001024126
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 4, 2017 | A | 5,000 | $0.00 | A | 5,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $2.10 | Jan 4, 2017 | A | 15,000 | A | — | Jan 4, 2027 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1Represents a grant of restricted share units that vest in three equal installments of approximately 1,250 shares with the first installment vesting on the first anniversary of January 4, 2017 and the final installment vesting on the fourth anniversary of the vesting start date.
- F2The stock option vests in annual installments of approximately 3,750 shares, commencing on the first anniversary of January 4, 2017, with the final installment vesting on the fourth anniversary of the vesting start date.